NCT06978400 2025-05-18
A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
Blokhin's Russian Cancer Research Center
Phase 2 Recruiting
Blokhin's Russian Cancer Research Center
Al-Azhar University
Amgen
Amgen
Amgen
Amgen
AIO-Studien-gGmbH
Amgen
Amgen